This is a classic toxic-financing ELOC — expect heavy downward pressure on the stock as the market prices in future dilutive draws. Monitor whether the Company actually draws down (vs. optionality) — any VWAP Purchase Notice will trigger immediate selling by the investor to hedge. The $3.00 conversion floor on the Commitment Note provides a soft price floor only; if OPTH trades below $3, conversion becomes uneconomical and the note becomes straight debt. Given the $16M market cap, the $100M facility size is massively dilutive relative to current float.
Price Chart
Executive Summary
Optimi Health Corp. entered a $100M at-the-market equity line of credit (ELOC) with Seven Knots, LLC, issuing a $1.5M convertible promissory note as commitment consideration. The facility gives Optimi the option, but not the obligation, to sell up to $2M of shares per draw at a 3% discount to the lower of the lowest sale price or VWAP, subject to a 4.99% beneficial ownership cap. This structure is highly dilutive to existing shareholders and signals acute cash needs, while the forced conversion floor of $3.00 per share provides a potential price floor.
Key Facts
- Up to $100M ELOC with Seven Knots, LLC — Company has discretion to draw, but investor must purchase
- Issued unsecured, non-interest-bearing $1.5M Initial Commitment Note (convertible at 95% of 20-day VWAP, floor $3.00/share)
- Second $500K Commitment Note issuable if $7M in draws completed
- Per-draw cap of $2M; pricing at 97% of the lower of lowest sale price or VWAP on purchase date
- 4.99% beneficial ownership limit on ELOC shares; 2.99% limit on conversion shares
- Placement agent Joseph Gunnar & Co. gets 3% of gross proceeds
- $35,000 expense reimbursement to investor paid at closing
- Commitment Notes fully earned whether or not any draws occur
Financial Impact
Up to $100M in potential equity issuance over time; $1.5M commitment note issued immediately (convertible at 95% of 20-day VWAP with $3 floor); $35K upfront expense
Risk Factors
- Extreme dilution risk — $100M facility is 6x current market cap
- Price suppression from investor's hedging/short-selling upon each drawdown
- Commitment Notes are fully earned regardless of future draws, creating a fixed dilution overhang
- Potential for a 'death spiral' as lower stock prices enable larger share issuances per draw
- Registration statement required for resale — any delay could spook the market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-090286 |
| Document: ea030225801ex99-4.htm | 0001213900-26-090286 |
| Document: ea030225801ex99-5.htm | 0001213900-26-090286 |
| Document: ea030225801ex99-3.htm | 0001213900-26-090286 |
| Document: ea0302258-6k_optimi.htm | 0001213900-26-090286 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $3.36 | awaiting T+5 | — | $3.12 (−7.14%) |
Oct 20, 2026 6d ago | 6-K | $3.36 | awaiting T+5 | — | $3.12 (−7.14%) |
Oct 7, 2026 19d ago | 6-K | $4.04 $3.17 | ▼ −21.66% | ▼ −20.68% | $3.12 (−22.77%) |
Oct 5, 2026 21d ago | SC 13G/A | $4.13 $3.50 | ▼ −15.25% | ▼ −15.12% | $3.12 (−24.46%) |
Sep 29, 2026 27d ago | 6-K | $4.78 $4.13 | ▼ −13.60% | ▼ −15.55% | $3.12 (−34.73%) |
Sep 23, 2026 4w ago | 6-K | $4.96 $4.71 | ▼ −5.04% | ▼ −4.37% | $3.12 (−37.10%) |
Sep 22, 2026 4w ago | 6-K | $4.96 $4.78 | ▼ −3.63% | ▼ −2.44% | $3.12 (−37.10%) |
Sep 16, 2026 5w ago | 6-K | $4.90 $4.96 | ▲ +1.22% | ▼ −0.60% | $3.12 (−36.33%) |
Sep 10, 2026 6w ago | 6-K | $4.50 $4.96 | ▲ +10.22% | ▲ +10.72% | $3.12 (−30.67%) |
Aug 26, 2026 8w ago | 6-K | $4.89 $4.70 | ▲ +3.89% | ▲ +4.15% | $3.12 (+36.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers